SCHEMBL6069744

SCHEMBL6069744

O=C(O)c1ccc2c(c1)NC(=O)C1CCCC21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.46
PABPC1 P11940 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTT P42858 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DDB1 Q16531 3/20 0.39
CRBN Q96SW2 3/20 0.39
KMO O15229 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 1/20 0.37
GAA P10253 1/20 0.37
HCAR3 P49019 3/20 0.36
TDP2 O95551 1/20 0.36
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 2/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24307083 0.85 POLB (0.48) HSD17B10PABPC1TDP1L3MBTL1POLB
SCHEMBL25822110 0.83 ALOX15 (0.54) HSD17B10L3MBTL1SMN1; SMN2HTTMEN1
SCHEMBL6642433 0.77 NOS3 (0.44) TDP1L3MBTL1DDB1CRBNGAA
SCHEMBL6645276 0.77 NOS3 (0.44) MEN1KMT2ADDB1CRBN
SCHEMBL6137666 0.77 PTGS1 (0.40) HSD17B10SMN1; SMN2HTTKMT2AKDM4E
SCHEMBL6069563 0.77 DDB1 (0.39) DDB1CRBNALOX5HPGDENPP2
SCHEMBL6069742 0.76 CYP2A6 (0.33) HSD17B10TDP1SMN1; SMN2KDM4EALDH1A1
SCHEMBL9773848 0.75 POLB (0.57) HSD17B10PABPC1TDP1L3MBTL1POLB
SCHEMBL6069808 0.74 NOX1 (0.37) TDP1POLBSMN1; SMN2MEN1KMT2A
SCHEMBL6643305 0.73 NOS3 (0.48) SMN1; SMN2MEN1KMT2ADDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067667-B2 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-27 US disclosed
US-20040127712-A1 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors JAROCH STEFAN (DE) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127712-A1 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors NOS3, NOS1, NOS2 HSD17B10 481/4885PABPC1 3276/4885TDP1 1264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.